DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mirena Observational Program

Information source: Bayer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Contraception; Menorrhagia; Endometrial Hyperplasia; Estrogen Replacement Therapy

Intervention: Levonorgestrel (Mirena, BAY86-5028) (Drug)

Phase: N/A

Status: Active, not recruiting

Sponsored by: Bayer

Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer


Mirena is used for long-term in Kazakhstan, and in our observational program we would like to study patients distribution per indications of Mirena, and also patient compliance within a year after Mirena insertion. For patients with all approved indications for Mirena use: contraception, treatment of menorrhagia and protection from endometrial hyperplasia during estrogen replacement therapy

Clinical Details

Official title: Mirena Observational Program

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Patient distribution per indication

Secondary outcome: Patient compliance


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.


Inclusion Criteria:

- Patients older than 18 years with previously taken decision of their gynecologist to

insert Mirena according to registered indications Exclusion Criteria:

- All patients with contraindications to Mirena insertion, according to approved

prescribing information.

Locations and Contacts

Many Locations, Kazakhstan
Additional Information

Click here and search for drug information provided by the FDA.

Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.

Starting date: June 2009
Last updated: August 18, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017